Row erupts as doctors call to BAN Lemsip because 'it doesn't work' - but some insist it's the ONLY thing that eases a blocked nose
Health experts have argued that UK customers are being hoodwinked by the drug firms behind the 'useless' medicines - which include Sudafed, Lemsip and Beechams.
Pharmaceutical Technology2h
Autolus secures FDA approval for CAR-T cell therapy use in ALL
Autolus has not yet disclosed the list price for Aucatzyl, which is also under review for market authorisation in the UK and ...
The cold and flu remedies that REALLY work: As US regulators warn many popular treatments simply don't make a difference, these are the ones that do
At the first sign of a runny nose many people dash out to buy a cold and flu remedy - but soon that might become harder to do ...
Asia One7h
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...
News Medical2d
Novel bladder cancer treatment gains MHRA approval in the UK
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®â–¼ (erdafitinib) as a monotherapy for the treatment ...
The FDA Is Finally Pulling a Useless Cold Medicine From the Market
And finally, the agency is making plans to pull it from pharmacy and grocery store shelves.The medicines will remain ...
Lemsip and other cold and flu decongestants are ‘not effective’ as experts call for them be pulled from shelves
LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...
What is oral phynylephrine and why does the FDA want to remove it from cold medicine?
Oral phenylephrine is used in over-the-counter products like Sudafed and Dayquil to help temporarily relieve the common symptom of colds and allergies. Phenylephrine has been sold for more than 75 ...
abc7NY3d
FDA moves to pull nasal decongestant in some cold medicines from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...
FiercePharma3d
J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
FDA proposes removing ineffective decongestant found in most cold medicine
The Consumer Healthcare Products Association, which represents manufacturers and marketers of over-the-counter medicines, ...
FDA proposes ending use of decongestant found in many cold, allergy medicines
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.